← Evidence map

ArticleRheumatology (Oxford, England)2010

Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?

Robert W Simms et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2010
2011
2012
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 20032221